NewsProject OverviewExemption ConsultationsSubstance Review 2018Earlier ConsultationsRegistrationImprint

Stakeholder consultation held as part of a study to review a possible restriction of the substance group of small brominated alkyl alcohols under Directive 2011/65/EU (RoHS 2)“

The stakeholder consultation shall run for six weeks, between 23.09.2016 and 04.11.2016 and covers the review of a possible restriction of new substances under the RoHS Directive.

Please see the consultation page: SBAA (small brominated alkyl alcohols)

Guidance document

The guidance document contains information on

  • the objective of the consultation,
  • how to submit your contribution,
  • contact details.

> Download guidance document on the stakeholder consultation (PDF)

The section SBAA contains further necessary information (e.g. background document, questionnaire and reports of earlier studies).

Results of the consultation and next steps

Non-confidential information submitted during the consultation will be posted on this website. Further exchange with stakeholders will be held after the consultation has ended for those issues where further need for information and / or need for (technical) discussion has been identified.

Target groups

The consultation is targeted at the following groups:

·         EEE industry

·         EEE industry federations

·         Consultancies

·         Research institutions & universities

·         NGOs

·         Public administrations

The following representatives from these groups have currently registered on the list. This list will be updated regularly depending on new registrations of interested stakeholders.


> Download list of interested stakeholders

Please take note that by contributing to the consultation you agree that the information and data submitted may be used for the purpose of the evaluation of a possible restriction of small brominated alkyl alcohols under the RoHS Directive.

Should there be any mistakes or uncertainties we apologise for the inconvenience and kindly ask you to provide us with a short indication.